Currently, it is accepted that peptides can be derived from α-synuclein in PD patients, which is then displayed by MHC-I and activates CD8 cytotoxic T cell responses (Sulzer et al., 2017; Hobson and Sulzer, 2022). Here, CD8A is linked to Parkinson disease.